Recent Progress of Activity-Based Fluorescent Probes for Imaging Leucine Aminopeptidase

Leucine Aminopeptidase (LAP) is an important protease that can specifically hydrolyze Leucine residues. LAP occurs in Microorganisms, Plants, Animals, and humans and is involved in a variety of physiological processes in the human body. In the physiological system, abnormal levels of LAP are associated with a variety of diseases and pathological processes, such as Cancer and drug-induced liver injury; thus, LAP was chosen as the early biochemical marker for many physiological processes, including Cancer. Considering the importance of LAP in physiological and pathological processes, it is critical that high-efficiency and dependable technology be developed to monitor LAP levels. Herein, we summarize the organic small molecule fluorescence/chemiluminescence probes used for LAP detection in recent years, which can image LAP in Cancer, drug-induced liver injury (DILI), and bacteria. It can also reveal the role of LAP in tumors and differentiate the serum of cirrhotic, drug-induced liver injury and normal models.

fluorescence imaging; fluorescence probe; leucine aminopeptidase (LAP).